Sarclisa (isatuximab-irfc) for the Treatment of Multiple Myeloma

Sarclisa® (isatuximab-irfc) is available as an intravenous (IV) injection. Credit: Sanofi-Aventis.



  • Sarclisa
  • Sarclisa
  • Sarclisa
  • Sarclisa